Magnesium Sulfate in Treatment of Hypoxic Pulmonary Hypertension in Experimental Animal

张伟利,单海燕,李笑宏,林建海
DOI: https://doi.org/10.3969/j.issn.0253-9934.2002.07.013
2002-01-01
Abstract:Objective To evaluate the effects of magnesium sulfate (MgSO 4) in the treatment of persistent pulmonary hypertension of newborn (PPHN). Methods Hypoxia-induced pulmonary hypertension models of seven piglets were constructed. A catheter was inserted through the external jugular vein and advanced to the right atrium, right ventricle and into the pulmonary artery to measure pulmonary arterial pressure (PAP) and cardiac output (CO). Another catheter was inserted into the right femoral artery to measure systemic arterial pressure (SAP). Heart rate (HR), arterial oxygen saturation (SaO 2), arterial blood gases, and serum magnesium (Mg ) concentrations were estimated. Results After hypoxia was induced for 10 minutes, there were significant increases in systolic PAP (SPAP), diastolic PAP (DPAP) and mean PAP (MPAP) (42.1%±19.4%, 46.8%±23.9% and 39.7%±22.1% respectively; P 0.01). Post MgSO 4 infusion, significant decreases occurred in SPAP, DPAP and MPAP (25.2%± 5.4%, 25.5%±6.3% and 22.5%±5.8% respectively; P 0.01), while systolic SAP remained unchanged ( P 0.05), but serum Mg  rose significantly from (0.79±0.12) mmol/L to (2.78±1.11) mmol/L following the infusion of MgSO 4. Conclusion Magnesium sulfate decreases PAP significantly and improves PO 2 with less effect on the SAP, HR and CO.
What problem does this paper attempt to address?